Tissue Regenix Group
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Tissue Regenix Group's past years’ income statements indicate that its last revenue has increased compared to the previous period by 48% to $29,493,000. The net income raised on -$1,713,000 and profit margin reached -6%. Total operating expenses were $14,434,000.

Profit Margin

Tissue Regenix Group plc (LSE:TRX.L): Profit margin
2011 0 -5.42M
2012 0 -2.68M
2016 1.16M -13.40M -1153.19%
2016 1.57M -10.67M -678.17%
2018 11.61M -8.18M -70.45%
2019 13.03M -6.97M -53.5%
2020 12.82M -9.70M -75.68%
2021 14.35M -3.48M -24.27%
2022 19.87M -2.18M -11.01%
2023 29.49M -1.71M -5.81%

TRX.L Income Statement (2011 – 2023)

2023 2022 2021 2020 2019 2018 2016 2015 2012 2011
Revenue
Revenue
29.49M19.87M14.35M12.82M13.03M11.61M1.57M1.16M00
Cost of revenue
15.45M10.73M8.72M7.69M8.06M6.87M714.54K219.32K00
Gross profit
14.04M9.13M5.63M5.13M4.97M4.74M859.63K942.81K00
Operating exp.
Research and development
000546K1.36M1.63M3.41M01.08M653K
Selling and marketing
0-2.51M-3.88M456.54K989.93K-6.67M0000
Total operating expenses
14.43M10.75M8.61M9.25M12.15M12.95M13.05M15.52M2.98M1.94M
Operating income
-394K-1.61M-2.98M-4.11M-7.18M-8.21M-12.19M-14.58M-2.98M-1.94M
Other income (expenses), net
-948.66K-683.56K-756.2K-6.12M-480K-668K249.81K303.35K59K3.72M
Income before tax
-1.34M-2.29M-3.73M-10.24M-7.66M-8.87M-11.94M-14.28M-2.92M-5.66M
Income tax expense
-12K-188.34K-114.15K-533K-554K-620K-1.12M-750.55K-239K-238K
Net income
-1.71M-2.18M-3.48M-9.70M-6.97M-8.18M-10.67M-13.40M-2.68M-5.42M
Earnings per share
Basic EPS
-0.02-0.03-0.04-0.22-0.6-0.70-1.8-0.00-0.01
Diluted EPS
-0.02-0.03-0.04-0.22-0.6-0.70-1.8-0.00-0.01
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source